health pharma news today obesity drugs glp-1 Popular medications may have benefits that extend beyond weight loss and blood sugar control, a new study finds A major breakthrough in the

Food and Drug Administration (FDA) in 2005 for the treatment of type 2 diabetes

doi: 10.1186/s12943-024-02140-6 [DOI] [PMC free article] [PubMed] [Google Scholar] 68

According to the World Health Organization, over 750 million people worldwide suffer from obesity, and it accounts for 5% of global deaths annually

Recuperato da: Petroni ML, Montesi L, Colosimo S, Caletti MT, Mazzotti A, Marchesini G

If we feature your Disaster Averted in our Diabetes Clinical Mastery Series e-newsletter, you will receive a $25 gift card

BARRIERS TO SWITCHING FROM ONE GLP1RA TO ANOTHER Patients may be reluctant to switch between GLP1RAs